Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.

Kanatani I, Lin X, Yuan X, Manorek G, Shang X, Cheung LH, Rosenblum MG, Howell SB.

Cancer Chemother Pharmacol. 2011 Oct;68(4):979-90. doi: 10.1007/s00280-011-1573-4. Epub 2011 Feb 16.

3.
4.
5.

Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex.

Meehan TP, Harmon BG, Overcast ME, Yu KK, Camper SA, Puett D, Narayan P.

J Mol Endocrinol. 2005 Apr;34(2):489-503.

PMID:
15821112
7.
8.
10.

Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.

Rivero-Müller A, Vuorenoja S, Tuominen M, Wacławik A, Brokken LJ, Ziecik AJ, Huhtaniemi I, Rahman NA.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):17-25. Epub 2007 Feb 12. Review.

PMID:
17363137
11.

The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.

Mohamedali KA, Cao Y, Cheung LH, Hittelman WN, Rosenblum MG.

Mol Cancer Ther. 2013 Oct;12(10):2055-66. doi: 10.1158/1535-7163.MCT-13-0165. Epub 2013 Jul 15.

12.
13.

Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG).

Viswanath G, Chatterjee S, Roy P.

Mol Cell Endocrinol. 2007 Jun 30;272(1-2):14-21. Epub 2007 May 4.

PMID:
17548147
14.

Luteinizing hormone receptor mRNA down-regulation is mediated through ERK-dependent induction of RNA binding protein.

Menon B, Franzo-Romain M, Damanpour S, Menon KM.

Mol Endocrinol. 2011 Feb;25(2):282-90. doi: 10.1210/me.2010-0366. Epub 2010 Dec 8.

15.

Granzyme B-induced cell death involves induction of p53 tumor suppressor gene and its activation in tumor target cells.

Meslin F, Thiery J, Richon C, Jalil A, Chouaib S.

J Biol Chem. 2007 Nov 9;282(45):32991-9. Epub 2007 Sep 13.

17.

EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.

Oberoi P, Jabulowsky RA, Bähr-Mahmud H, Wels WS.

PLoS One. 2013;8(4):e61267. doi: 10.1371/journal.pone.0061267. Epub 2013 Apr 3.

18.

Leutropin/beta-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface.

Moyle WR, Bernard MP, Myers RV, Marko OM, Strader CD.

J Biol Chem. 1991 Jun 15;266(17):10807-12.

19.

Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.

Sonoda N, Katabuchi H, Tashiro H, Ohba T, Nishimura R, Minegishi T, Okamura H.

Placenta. 2005 Apr;26(4):298-307.

PMID:
15823616
20.

MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone.

Cui J, Eldredge JB, Xu Y, Puett D.

PLoS One. 2011;6(7):e21730. doi: 10.1371/journal.pone.0021730. Epub 2011 Jul 12.

Supplemental Content

Support Center